- Home
- PFSI vs CORT Comparison
PFSI vs CORT Comparison
Compare PFSI & CORT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PFSI
- CORT
- Stock Information
- Founded
- PFSI 2008
- CORT 1998
- Country
- PFSI United States
- CORT United States
- Employees
- PFSI N/A
- CORT N/A
- Industry
- PFSI Finance: Consumer Services
- CORT Biotechnology: Pharmaceutical Preparations
- Sector
- PFSI Finance
- CORT Health Care
- Exchange
- PFSI Nasdaq
- CORT Nasdaq
- Market Cap
- PFSI 6.9B
- CORT 7.6B
- IPO Year
- PFSI 2013
- CORT N/A
- Fundamental
- Price
- PFSI $129.47
- CORT $71.99
- Analyst Decision
- PFSI Buy
- CORT Strong Buy
- Analyst Count
- PFSI 6
- CORT 4
- Target Price
- PFSI $138.67
- CORT $139.00
- AVG Volume (30 Days)
- PFSI 422.6K
- CORT 962.0K
- Earning Date
- PFSI 10-21-2025
- CORT 11-04-2025
- Dividend Yield
- PFSI 0.92%
- CORT N/A
- EPS Growth
- PFSI 189.98
- CORT N/A
- EPS
- PFSI 9.29
- CORT 1.11
- Revenue
- PFSI $2,965,619,000.00
- CORT $716,080,000.00
- Revenue This Year
- PFSI $6.07
- CORT $28.85
- Revenue Next Year
- PFSI $24.34
- CORT $34.98
- P/E Ratio
- PFSI $14.01
- CORT $64.21
- Revenue Growth
- PFSI 47.97
- CORT 25.71
- 52 Week Low
- PFSI $85.74
- CORT $42.01
- 52 Week High
- PFSI $134.56
- CORT $117.33
- Technical
- Relative Strength Index (RSI)
- PFSI 62.35
- CORT 38.48
- Support Level
- PFSI $128.68
- CORT $70.89
- Resistance Level
- PFSI $134.08
- CORT $74.77
- Average True Range (ATR)
- PFSI 3.83
- CORT 4.05
- MACD
- PFSI 1.00
- CORT -1.07
- Stochastic Oscillator
- PFSI 74.48
- CORT 14.14
About PFSI PennyMac Financial Services Inc.
PennyMac Financial Services Inc is a specialty financial services firm with a comprehensive mortgage platform and integrated business focused on the production and servicing of U.S. residential mortgage loans. The company operates through two segments: production and servicing. The production segment performs loan origination, acquisition and sale activities. The servicing segment performs loan servicing for newly originated loans.
About CORT Corcept Therapeutics Incorporated
Corcept Therapeutics Inc is a commercial-stage pharmaceutical company engaged in the discovery and development of medications that treat severe metabolic, oncologic and neuropsychiatric disorders by modulating the effect of the hormone cortisol. The company's compounds are being evaluated in clinical trials as potential treatments for a variety of serious disorders - hypercortisolism, advanced ovarian cancer, prostate cancer, ALS, and MASH.